Primary Site >> Pancreatic Cancer

Gene >> CD33

Journal: Hematology Am Soc Hematol Educ Program. 2000:394-408.
Title: Emerging Therapies: Spectrum of Applications of Monoclonal Antibody Therapy.
Author: Waldmann, Thomas A.|Levy, Ronald|Coller, Barry S.
PMID: 11701553
Journal: Br J Cancer. 2010 Feb 2;102(3):583-93.
Title: Role of reactive oxygen species in brucein D-mediated p38-mitogen-activated protein kinase and nuclear factor-kappaB signalling pathways in human pancreatic adenocarcinoma cells.
Author: Lau, S T|Lin, Z X|Leung, P S
PMID: 20068565
Journal: PLoS One. 2013;8(1):e54824.
Title: Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study.
Author: Basso, Daniela|Fogar, Paola|Falconi, Massimo|Fadi, Elisa|Sperti, Cosimo|Frasson, Chiara|Greco, Eliana|Tamburrino, Domenico|Teolato, Sara|Moz, Stefania|Bozzato, Dania|Pelloso, Michela|Padoan, Andrea|De Franchis, Giuseppe|Gnatta, Elisa|Facco, Monica|Zambon,
PMID: 23359812
Journal: Cancer Res. 2013 May 15;73(10):3007-18.
Title: Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner.
Author: Mace, Thomas A|Ameen, Zeenath|Collins, Amy|Wojcik, Sylwia|Mair, Markus|Young, Gregory S|Fuchs, James R|Eubank, Tim D|Frankel, Wendy L|Bekaii-Saab, Tanios|Bloomston, Mark|Lesinski, Gregory B
PMID: 23514705
Journal: Oncoimmunology. 2013 Jun 1;2(6):e24441.
Title: The S100A8/A9 complex reduces CTLA4 expression by immature myeloid cells: Implications for pancreatic cancer-driven immunosuppression.
Author: Basso, Daniela|Fogar, Paola|Plebani, Mario
PMID: 23894703
Journal: J Immunol Res. 2014;2014:879897.
Title: Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients.
Author: Khaled, Yazan S|Ammori, Basil J|Elkord, Eyad
PMID: 24741628
Journal: Cancer Immunol Immunother. 2015 Feb;64(2):149-59.
Title: Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease.
Author: Markowitz, Joseph|Brooks, Taylor R|Duggan, Megan C|Paul, Bonnie K|Pan, Xueliang|Wei, Lai|Abrams, Zachary|Luedke, Eric|Lesinski, Gregory B|Mundy-Bosse, Bethany|Bekaii-Saab, Tanios|Carson, William E 3rd
PMID: 25305035
Journal: Cancer Sci. 2015 Jun;106(6):672-86.
Title: Inflammatory features of pancreatic cancer highlighted by monocytes/macrophages and CD4+ T cells with clinical impact.
Author: Komura, Takuya|Sakai, Yoshio|Harada, Kenichi|Kawaguchi, Kazunori|Takabatake, Hisashi|Kitagawa, Hirohisa|Wada, Takashi|Honda, Masao|Ohta, Tetsuo|Nakanuma, Yasuni|Kaneko, Shuichi
PMID: 25827621
Journal: Oncotarget. 2016 Nov 1;7(44):71198-71210.
Title: Prognostic value of PDL1 expression in pancreatic cancer.
Author: Birnbaum, David J|Finetti, Pascal|Lopresti, Alexia|Gilabert, Marine|Poizat, Flora|Turrini, Olivier|Raoul, Jean-Luc|Delpero, Jean-Robert|Moutardier, Vincent|Birnbaum, Daniel|Mamessier, Emilie|Bertucci, Francois
PMID: 27589570
Journal: Oncotarget. 2017 Feb 14;8(7):10785-10808.
Title: Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.
Author: Pathangey, Latha B|McCurry, Dustin B|Gendler, Sandra J|Dominguez, Ana L|Gorman, Jessica E|Pathangey, Girish|Mihalik, Laurie A|Dang, Yushe|Disis, Mary L|Cohen, Peter A
PMID: 27974697
Journal: Zhonghua Wai Ke Za Zhi. 2018 Jun 1;56(6):464-470.
Title: [Prognostic value of tumor infiltration immune cells in pancreatic cancer].
Author: Zhao, K L|Liu, J|Jiang, W N|Hao, J H
PMID: 29886672